Authors: FERRARA F ANNUNZIATA M COPIA C MAGRIN S MELE G MIRTO S

Citation: F. Ferrara et al., THERAPEUTIC OPTIONS AND TREATMENT RESULTS FOR PATIENTS OVER 75 YEARS OF AGE WITH ACUTE MYELOID-LEUKEMIA, Haematologica, 83(2), 1998, pp. 126-131

Authors: FERRARA F DINOTO R ANNUNZIATA M COPIA C LOPARDO C BOCCUNI P SEBASTIO L DELVECCHIO L

Citation: F. Ferrara et al., IMMUNOPHENOTYPIC ANALYSIS ENABLES THE CORRECT PREDICTION OF T(8-21) IN ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 444-448

Authors: FERRARA F SEBASTIO L DINOTO R ANNUNZIATA M COPIA C PUGLIESE MT RUSSO C CIMINO R DELVECCHIO L

Citation: F. Ferrara et al., ACUTE MYELOID-LEUKEMIA (AML) WITH T(8-21) DISPLAYS AN EXCLUSIVE PHENOTYPE - PROPOSAL OF A MODEL HIGHLY PREDICTIVE FOR THIS CYTOGENETIC ABNORMALITY, Blood, 90(10), 1997, pp. 3688-3688

Authors: FERRARA F MIRTO S MONTILLO M MELE G TEDESCHI A CIOLLI S ANNUNZIATA M COPIA C MAGRIN S LEONI F

Citation: F. Ferrara et al., FLUDARABINE, CYTARABINE AND G-CSF (FLAG) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS), Blood, 90(10), 1997, pp. 371-371